|
|
Article: New treatment for diabetes.(Updates)
- Article from:
- FDA Consumer
- Article date:
- January 1, 2007
CopyrightCOPYRIGHT 2007 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The FDA has approved Januvia (sitagliptin phosphate) tablets, the first diabetes treatment approved in a new class of drugs, DPP-IV inhibitors, that enhances the body's own ability to lower elevated blood sugar.
Januvia was approved in October 2006 to improve blood sugar levels in people with type 2 diabetes. Januvia can be used alone or in combination with two other commonly prescribed oral diabetes medications, metformin or a peroxisome proliferator-activated receptor gamma (PPAR) agonist, when either of these drugs alone, along with diet and exercise, doesn't provide adequate blood sugar control.
Type 2 diabetes is the most common form of the disease, ...